PMC:7156805 / 1595-1722 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"52","span":{"begin":45,"end":53},"obj":"Disease"}],"attributes":[{"id":"A52","pred":"tao:has_database_id","subj":"52","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ells could limit antibody production.3\nFig 1 COVID-19 viral immune response and targets of common dermatologic immunomodulators"}

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T26","span":{"begin":17,"end":25},"obj":"Body_part"}],"attributes":[{"id":"A26","pred":"fma_id","subj":"T26","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"ells could limit antibody production.3\nFig 1 COVID-19 viral immune response and targets of common dermatologic immunomodulators"}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T12","span":{"begin":45,"end":53},"obj":"Disease"}],"attributes":[{"id":"A12","pred":"mondo_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"ells could limit antibody production.3\nFig 1 COVID-19 viral immune response and targets of common dermatologic immunomodulators"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T13","span":{"begin":111,"end":127},"obj":"Chemical"}],"attributes":[{"id":"A13","pred":"chebi_id","subj":"T13","obj":"http://purl.obolibrary.org/obo/CHEBI_50846"}],"text":"ells could limit antibody production.3\nFig 1 COVID-19 viral immune response and targets of common dermatologic immunomodulators"}

    LitCovid-PD-GO-BP

    {"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T14","span":{"begin":17,"end":36},"obj":"http://purl.obolibrary.org/obo/GO_0002377"},{"id":"T15","span":{"begin":60,"end":75},"obj":"http://purl.obolibrary.org/obo/GO_0006955"}],"text":"ells could limit antibody production.3\nFig 1 COVID-19 viral immune response and targets of common dermatologic immunomodulators"}